Report cover image

Swine Vaccines Market Growth, Size, Trends Analysis - By Product, By Disease Type, By Route of Administration, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Mar 18, 2025
Length 272 Pages
SKU # SPER20019408

Description

Swine Vaccines Market Introduction and Overview

According to SPER market research, ‘Swine Vaccines Market Size- By Product, By Disease Type, By Route of Administration, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Swine Vaccines Market is predicted to reach 3.07 billion by 2034 with a CAGR of 5.77%.

Swine vaccinations are biological preparations used to shield pigs against infectious disorders caused by pathogenic bacteria, viruses, or other infectious agents. By stimulating the development of immunity in the pig’s immune system, these vaccinations reduce the severity of disease outbreaks and minimize financial losses associated with pig farming. Live attenuated, inactivated (killed), subunit, toxoid, and recombinant vaccines are the several types of swine vaccines.

Restraints: In some places, particularly in isolated or underdeveloped locations, maintaining the cold chain for vaccine distribution and storage might be difficult. The efficacy of vaccinations depends on ensuring that they are delivered to their intended recipients in the best possible form. Breach of biosecurity can result in disease outbreaks in swine herds, making vaccinations useless. While personnel training, appropriate quarantine protocols.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered

By Product, By Disease Type, By Route of Administration, By Distribution Channel.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Biogenesis Bago, Bioveta, a.s, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Incorporated, HIPRA, Indian Immunologicals Limited, Merck & Co., Inc., Phibro Animal Health Corporation, Vaxxinova.

Swine Vaccines Market Segmentation:

By Product: Based on the Product, Global Swine Vaccines Market is segmented as; Modified/Attenuated Live, Inactivated (Killed), others.

By Disease Type: Based on the Disease Type, Global Swine Vaccines Market is segmented as; Swine Influenza, Classical Swine Fever, Porcine Parvovirus, Porcine Circovirus Type 2, M.Hyo, Actinobacillus Pleuropneumonia, PRRS, Foot & Mouth Disease, Pseudorabies, PEDV.

By Route of Administration: Based on the Route of Administration, Global Swine Vaccines Market is segmented as; Injectables, Intranasal.

By Distribution Channel: Based on the Distribution Channel, Global Swine Vaccines Market is segmented as; Retail, E-Commerce, Hospital/Clinic Pharmacies.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Table of Contents

272 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Swine Vaccines Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Swine Vaccines Market
7. Global Swine Vaccines Market, By Product 2021-2034 (USD Million)
7.1. Modified/Attenuated Live
7.2. Inactivated (Killed)
7.3. Others
8. Global Swine Vaccines Market, By Disease Type 2021-2034 (USD Million)
8.1. Swine Influenza
8.2. Classical Swine Fever
8.3. Porcine Parvovirus
8.4. Porcine Circovirus Type 2
8.5. M.Hyo
8.6. Actinobacillus Pleuropneumonia
8.7. PRRS
8.8. Foot & Mouth Disease
8.9. Pseudorabies
8.10. PEDV
9. Global Swine Vaccines Market, By Route of Administration 2021-2034 (USD Million)
9.1. Injectables
9.2. Intranasal
10. Global Swine Vaccines Market, By Distribution Channel 2021-2034 (USD Million)
10.1. Retail
10.2. E-Commerce
10.3. Hospital/Clinic Pharmacies
11. Global Swine Vaccines Market, 2021-2034 (USD Million)
11.1. Global Swine Vaccines Market Size and Market Share
12. Global Swine Vaccines Market, By Region, 2021-2034 (USD Million)
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6. Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America
13. Company Profile
13.1. Biogenesis Bago
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Bioveta, a.s.
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. Boehringer Ingelheim International GmbH
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. Ceva Sante Animale
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Elanco Animal Health Incorporated
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. HIPRA
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Indian Immunologicals Limited
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Merck & Co., Inc.
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. Phibro Animal Health Corporation
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Vaxxinova
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us